The effect of diet type on the plasma disposition of triclabendazole in goats

被引:9
作者
Gokbulut, Cengiz [1 ]
Karademir, Umit
Boyacioglu, Murat
Akar, Ferda
机构
[1] Univ Adnan, Fac Vet Med, Dept Pharmacol & Toxicol, Aydin, Turkey
[2] Univ Adnan Menderes, Res & Dev Lab, Aydin, Turkey
关键词
diet; pharmacokinetics; triclabenclazole; goats;
D O I
10.1016/j.rvsc.2006.08.003
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The effect of two different diet types (concentrate feed+hay and grazing) on the pharmacokinetic profiles of triclabendazole following oral administration in goats was investigated. A total of 12 goats were randomly allocated into two groups which were either indoor and fed concentrate+hay ration (housed group) or were grazing on pasture (grazing group). Triclabendazole was administered orally to animals in two groups at 10 mg/kg bodyweight. Blood samples were collected from 1 h to 192 h post-treatment and analyzed by high performance liquid chromatography (HPLC). Feeding with different diets significantly effected the plasma disposition of triclabendazole sulphoxide. Maximum plasma concentration (C-max:13.22 +/- 12.81 mu g/ml), time to reach maximum plasma concentration (t(max):18.4 +/- 2.19 h), area under the curve (AUC:613 +/- 137 mu g h/ml), half-life (t(1/2): 24.77 +/- 1.94 h) and mean resident time (MRT:40.22 +/- 4.36 h) of triclabendazole sulphoxide in housed group were significantly different from those of grazing group (C-max: 10.17 +/- 1.51 mu g/ml, t(max):14.0 +/- 2.19 h., AUC: 406 +/- 98 mu g h/ml), t(1/2): 16.16 +/- 1.17 h and MRT: 34.48 +/- 4.40 h). It is concluded that anthelmintically more active sulphoxide metabolite has higher plasma concentration when triclabendazole is administered to goats fed with concentrate feed+hay compared to grazing goats. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:388 / 391
页数:4
相关论文
共 25 条
[1]   THE EFFECT OF LEVEL OF FEED-INTAKE ON THE PHARMACOKINETIC DISPOSITION OF OXFENDAZOLE IN SHEEP [J].
ALI, DN ;
HENNESSY, DR .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1995, 25 (01) :63-70
[2]  
ALI M, 1987, J VET PHARMACOL THER, V9, P442
[3]   METHYL 5(6)-PHENYLSULFINYL-2-BENZIMIDAZOLECARBAMATE, A NEW, POTENT ANTHELMINTIC [J].
AVERKIN, EA ;
BEARD, CC ;
DVORAK, CA ;
EDWARDS, JA ;
FRIED, JH ;
KILIAN, JG ;
SCHILTZ, RA ;
KISTNER, TP ;
DRUDGE, JH ;
LYONS, ET ;
SHARP, ML ;
CORWIN, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (11) :1164-1166
[4]   INVITRO FEBANTEL TRANSFORMATION BY SHEEP AND CATTLE RUMINAL FLUIDS AND METABOLISM BY HEPATIC SUBCELLULAR-FRACTIONS FROM DIFFERENT ANIMAL SPECIES [J].
BERETTA, C ;
FADINI, L ;
STRACCIARI, JM ;
MONTESISSA, C .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (19) :3107-3114
[5]  
BOGAN JA, 1987, PHYSL PHARM ASPECTS, P53
[6]   TREATMENT OF IMMATURE AND MATURE FASCIOLA-HEPATICA INFECTIONS IN SHEEP WITH TRICLABENDAZOLE [J].
BORAY, JC ;
CROWFOOT, PD ;
STRONG, MB ;
ALLISON, JR ;
SCHELLENBAUM, M ;
VONORELLI, M ;
SARASIN, G .
VETERINARY RECORD, 1983, 113 (14) :315-317
[7]   Lack of reversion in triclabendazole-resistant Fasciola hepatica [J].
Borgsteede, FHM ;
Moll, L ;
Vellema, P ;
Gaasenbeek, CPH .
VETERINARY RECORD, 2005, 156 (11) :350-351
[8]  
Capece BPS, 2001, J ANIM SCI, V79, P1288
[9]   Triclabendazole: new skills to unravel an old(ish) enigma [J].
Fairweather, I .
JOURNAL OF HELMINTHOLOGY, 2005, 79 (03) :227-234
[10]  
GYURIK RJ, 1981, DRUG METAB DISPOS, V9, P503